Goldman Sachs analysts, led by David Kostin, warned that the S&P 500 rally may face further headwinds following a recent 5% ...

Glissmann, head of asset allocation research at Goldman Sachs, on the outperformance of European and Chinese stocks over the ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00. The ...

The number of people registering as jobless in Spain fell 0.23% in February from a month earlier, or by 5,994 people, leaving ...

American Airlines Group (NASDAQ:AAL – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $30.00 to $26 ...

Redfin (NASDAQ:RDFN – Free Report) had its price target reduced by JPMorgan Chase & Co. from $8.00 to $7.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a ...

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ...

European defence company shares rallied for a second day on Tuesday, after U.S. President Donald Trump paused military aid to Ukraine.

China and Hong Kong stocks slipped on Tuesday, as new U.S. tariffs on Chinese imports were set to take effect, while ...

HC Wainwright restated their buy rating on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research report released on Monday morning,Benzinga reports. They currently have a $54.00 ...

Japan's output gap in the October-December quarter turned positive for the first time in six quarters, the Cabinet Office ...

Rocket Lab USA (NASDAQ:RKLB – Free Report) had its price target decreased by Wells Fargo & Company from $22.00 to $21.00 in a report released on Monday morning,Benzinga reports. Wells Fargo & Company ...